9 USE OF UMBILICAL CORD BLOOD TRANSFUSION IN SICKLE CELL ANEMIA PATIENTS

Tìm thấy 10,000 tài liệu liên quan tới từ khóa "9 USE OF UMBILICAL CORD BLOOD TRANSFUSION IN SICKLE CELL ANEMIA PATIENTS":

Chapter 099. Disorders of Hemoglobin (Part 7) ppt

CHAPTER 099 DISORDERS OF HEMOGLOBIN PART 7

Chapter 099. Disorders of Hemoglobin (Part 7) Clinical Manifestations of Sickle Cell Trait Sickle cell trait is usually asymptomatic. Anemia and painful crises are exceedingly rare. An uncommon but highly distinctive symptom is painless hematuria oft[r]

5 Đọc thêm

báo cáo hóa học:" Hydroxyurea and sickle cell anemia: effect on quality of life" pptx

BÁO CÁO HÓA HỌC:" HYDROXYUREA AND SICKLE CELL ANEMIA: EFFECT ON QUALITY OF LIFE" PPTX

each outcome measure. This initial model was expandedin a step-wise fashion to include other characteristicsrelated to outcomes of the treatment that could poten-tially be related to QOL. Interaction tests were performedbefore combining first-order terms in more comprehen-sive models.[r]

8 Đọc thêm

Management of Sickle Cell Disease in Children doc

MANAGEMENT OF SICKLE CELL DISEASE IN CHILDREN DOC

transfer2. Monitoring Children receiving IV morphine must be carefully monitored for signs of opioid toxicity which may include: hypotension, bradycardia, drowsiness, coma, pinpoint pupils, cold clammy skin, and hypoventilation. Monitoring will be according to the Monitoring Guidelines for

15 Đọc thêm

Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer

PREDICTION OF SURVIVAL PROGNOSIS AFTER SURGERY IN PATIENTS WITH SYMPTOMATIC METASTATIC SPINAL CORD COMPRESSION FROM NON-SMALL CELL LUNG CANCER

The aim of this study was to develop a scoring system for prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC).

9 Đọc thêm

Chapter 108. Hematopoietic Cell Transplantation (Part 2) ppt

CHAPTER 108 HEMATOPOIETIC CELL TRANSPLANTATION PART 2

collected in most circumstances, leads to rapid and sustained engraftment in virtually all cases. Compared to the use of autologous marrow, use of peripheral blood stem cells results in more rapid hematopoietic recovery, with granulocytes recov[r]

5 Đọc thêm

Chapter 058. Anemia and Polycythemia (Part 1) pps

CHAPTER 058 ANEMIA AND POLYCYTHEMIA PART 1

membrane generally have a lifelong clinical history typical of the disease process. Those with chronic hemolytic disease, such as hereditary spherocytosis, may actually present not with anemia but with a complication stemming from the prolonged increase in red cell destru[r]

5 Đọc thêm

Báo cáo khoa học: " Isolation and characterization of canine umbilical cord blood-derived mesenchymal stem cells" pps

BÁO CÁO KHOA HỌC: " ISOLATION AND CHARACTERIZATION OF CANINE UMBILICAL CORD BLOOD-DERIVED MESENCHYMAL STEM CELLS" PPS

with the cUCB-MSCs. However, the cUCB-MSCs did not appear to be able to differentiate into adipocytes, with non-morphological changes on containing oil droplets for 4 weeks (data not shown). The cUCB-MSCs were able to differentiate into neuronal cells, positively expressing neuronal protein markers[r]

7 Đọc thêm

THE CRUCIAL ROLE OF BLOOD VEGF KINETICS IN PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA RECEIVING CURATIVE CONCURRENT CHEMORADIOTHERAPY

THE CRUCIAL ROLE OF BLOOD VEGF KINETICS IN PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA RECEIVING CURATIVE CONCURRENT CHEMORADIOTHERAPY

To evaluate the role of blood vascular endothelial growth factor (VEGF) kinetics in patients with locally advanced esophageal squamous cell carcinoma (ESCC) receiving curative concurrent chemoradiotherapy (CCRT).

Đọc thêm

Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

IDENTIFYING PREDICTIVE BIOMARKERS OF CIMAVAXEGF SUCCESS IN NON–SMALL CELL LUNG CANCER PATIENTS

Immunosenescence biomarkers and peripheral blood parameters are evaluated separately as possible predictive markers of immunotherapy. Here, we illustrate the use of a causal inference model to identify predictive biomarkers of CIMAvaxEGF success in the treatment of Non–Small Cell Lung Cancer Patient[r]

8 Đọc thêm

Chapter 107. Transfusion Biology and Therapy (Part 1) ppsx

CHAPTER 107. TRANSFUSION BIOLOGY AND THERAPY (PART 1) PPSX

not cause hemolysis. Assay for these other alloantibodies is not routinely performed; however, they may be detected using special assays. ABO Antigens and Antibodies The first blood group antigen system, recognized in 1900, was ABO, the most important in transfusion med[r]

5 Đọc thêm

A study of prevalence of hepatitis-B and hepatitis-C infection in thalassemic patients in a tertiary care hospital, Jamnagar, Gujarat, India

A study of prevalence of hepatitis-B and hepatitis-C infection in thalassemic patients in a tertiary care hospital, Jamnagar, Gujarat, India

Thalassemia is an autosomal recessive disease causing haemolytic anaemia. The ideal treatment of these patients involves regular, 2-4 weekly blood transfusions. The major complications by this treatment are the transmission of transfusion acquired infections such as Hepatitis B virus infection, Hepa[r]

Đọc thêm

Tài liệu Understanding Growth Failure in Children With Homozygous Sickle-Cell Disease doc

TÀI LIỆU UNDERSTANDING GROWTH FAILURE IN CHILDREN WITH HOMOZYGOUS SICKLE-CELL DISEASE DOC

standard growth charts. The child’s weight falls lower than the third percentile or 20% below the ideal weight for his or her height. Growth velocity may have plateaued or fallen after a previously established curve (Kaneshiro & Zieve, 2009). Growth failure describes a linear growth rate bel[r]

8 Đọc thêm

PATHOLOGY SECRETS

PATHOLOGY SECRETS

because their nucleus and cytoplasm have shrunken in size. Tissues and organs composed ofatrophic cells are obviously smaller. However, they can also decrease in size because of loss of cells.Such atrophy is also called involution and is usually an age-related, irreversib[r]

469 Đọc thêm

báo cáo hóa học:" Health related quality of life in sickle cell patients: The PiSCES project" pot

BÁO CÁO HÓA HỌC:" HEALTH RELATED QUALITY OF LIFE IN SICKLE CELL PATIENTS: THE PISCES PROJECT" POT

hydroxyrea in sickle cell anemia. Controlled Clinical Trials 1995,16:432-446.16. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". Apractical guide for grading the cognitive state of patients forthe clinician. J Psychiatr Res 1975, 12(3):189-98.17. L[r]

7 Đọc thêm

Báo cáo hóa học: " Red blood cell transfusion in the critically ill patient" docx

BÁO CÁO HÓA HỌC: " RED BLOOD CELL TRANSFUSION IN THE CRITICALLY ILL PATIENT" DOCX

51. Middelburg RA, van de Watering LM, van der Bom JG: Blood transfusions:good or bad? Confounding by indication, an underestimated problem inclinical transfusion research. Transfusion 2010, 50:1181-1183.52. Ruttinger D, Wolf H, Kuchenhoff H, Jauch KW, Hartl WH: Red celltransfus[r]

9 Đọc thêm

Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer

Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer

Gefitinib, an EGFR-tyrosine kinase inhibitor, significantly improve prognosis in patients with advanced non-small cell lung cancer (NSCLC). The aim of this study was to evaluate the usefulness of MUC1 and vascular endothelial growth factor (VEGF) mRNA expression in peripheral blood as means of predi[r]

Đọc thêm

Báo cáo hóa học: "Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions" pot

BÁO CÁO HÓA HỌC: "SAFETY EVALUATION OF ALLOGENEIC UMBILICAL CORD BLOOD MONONUCLEAR CELL THERAPY FOR DEGENERATIVE CONDITIONS" POT

data. WM analyzed data and helped to draft the manuscript. BM participatedin the data analysis and helped to draft the manuscript. MZ participated inthe design of the study and carried out the clinical treatment. XL carried outthe clinical treatment and performed the statistical analysis. TI[r]

6 Đọc thêm

báo cáo hóa học:" Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with Hereditary Ataxia" pdf

BÁO CÁO HÓA HỌC:" HUMAN UMBILICAL CORD BLOOD-DERIVED MONONUCLEAR CELL TRANSPLANTATION: CASE SERIES OF 30 SUBJECTS WITH HEREDITARY ATAXIA" PDF

Cell Transplant 2009, 18(9):985-998.20. Javed MJ, Mead LE, Prater D, Bessler WK, Foster D, Case J, Goebel WS,Yoder MC, Haneline LS, Ingram DA: Endothelial Colony Forming Cells andMesenchymal Stem Cells are Enriched at Different Gestational Ages inHuman Umbilical Cord B[r]

5 Đọc thêm

Báo cáo sinh học: " Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with Hereditary Ataxia'''' docx

BÁO CÁO SINH HỌC: " HUMAN UMBILICAL CORD BLOOD-DERIVED MONONUCLEAR CELL TRANSPLANTATION: CASE SERIES OF 30 SUBJECTS WITH HEREDITARY ATAXIA'''' DOCX

, Matthew Gandjian4, Thomas E Ichim4*andXiang Hu2*AbstractBackground: The differential diagnosis for hereditary ataxia encompasses a variety of diseases characterized byboth autosomal dominant and recessive inheritance. There are no curative treatments available for theseneurodegenerative con[r]

5 Đọc thêm

báo cáo hóa học:" Stem cells from umbilical cord blood do have myogenic potential, with and without differentiation induction in vitro" pdf

BÁO CÁO HÓA HỌC STEM CELLS FROM UMBILICAL CORD BLOOD DO HAVE MYOGENIC POTENTIAL WITH AND WITHOUT DIFFERENTIATION INDUCTION IN VITRO PDF

333:861-863.10. Ervasti JM, Campbell KP: Membrane organization of the dys-trophin-glycoprotein complex. Cell 1991, 66:1121-1131.11. Vainzof M, Passos-Bueno MR, Canovas M, Moreira ES, Pavanello RC,Marie SK, Anderson LV, Bonnemann CG, McNally EM, Nigro V, Kun-kel LM, Zatz M: The sarcogly[r]

9 Đọc thêm

Cùng chủ đề